Health Condition 1: null- Hypertension Health Condition 2: I119- Hypertensive heart disease withoutheart failure
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Sanofi Synthelabo India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or Female patients 30-70 years of age 2. Essential hypertension which is uncontrolled (defined as systolic BP >= 140 mmHg or diastolic BP >= 90 mmHg (7)) on single anti-hypertensive agent 3. Investigators decides to add a second new anti-hypertensive agent 4. Signed Informed consent form obtained prior to initiation of the study
Exclusion criteria
Exclusion criteria: 1. Patient currently participating in a clinical trial 2. Patients unable to comply with the protocol requirements 3. Pregnancy 4. Patients with hypertensive urgencies and emergencies 5. Patients with known case of secondary hypertension 6. Patients with known case of complications due to hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with central systolic pressure 125 mmHg (8) at visit 1Timepoint: 01 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To compare brachial and central aortic blood pressure across various drugs classes at visit 1 and at 8th week ± 7days (visit 2), For details please see the protocol.Timepoint: 8th week ± 7days (visit 2) | — |
Countries
India
Contacts
Public ContactMs Vaishali Kanade
SANOFI -SYNTHELABO (I) PVT LIMITED
Outcome results
None listed